Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px
Document › Details

Bruker Corporation. (1/3/17). "Press Release: Bruker Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference". Billerica.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker Corporation (Group)
  Organisation 2 J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
  Product 2 analytical instrument
Index term Index term Bruker Corp–JPMorgan Chase: investor conference, 201701 supply service Bruker presents at JP Morgan Healthcare Conference 2017
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore)
     


Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 35th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Tony Mattacchione, Senior Vice President and CFO will present on behalf of the company on Monday, January 9th, 2017 at 8:00 AM Pacific Time.

A live audio webcast of the presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.


About Bruker Corporation

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: http://www.bruker.com.


Contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

   
Record changed: 2017-07-02

Advertisement

Picture BioM Forum Translationl Medicine 2018 Würzburg Germany iito 600x100px

More documents for Bruker Corporation (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top